Gonorrhoea vaccine becomes available at sexual health clinics in England
The vaccination programme is expected to save the NHS £7.9 million over the next decade and combat increasing levels of antibiotic-resistant strains of the disease.
The move aims to tackle rising levels of the sexually transmitted infection (STI) after cases in England topped 85,000 in 2023, the highest since records began in 1918.
The free jab will be on offer from Monday to patients at the highest risk of the sexually transmitted infection, including gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI.
The vaccine is an existing jab, known as 4CMenB, that is currently used to protect people against the meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis.
It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year.
The programme is targeted to those most at risk and could prevent up to 100,000 cases.
Gonorrhoea disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI).
Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment.
Ashley Dalton, the minister for public health and prevention, said: 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels.
'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance.
'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
17 minutes ago
- Bloomberg
Ozempic Maker's Plight Shows Managing Markets Counts Too
Ozempic-maker Novo Nordisk A/S saw its shares take a record plunge last week, sending their peak-to-trough collapse to 70% and returning them to levels last seen in 2022. The Danish drug giant's purpose may be to improve people's lives, but investors' shrinking gains from its opening of the anti-obesity market matter too. Novo's blind spot has been failing to see its share price as an asset to manage — and exploit. For years, Novo had a relatively quiet life as one member of an insulin oligopoly alongside US peer Eli Lilly & Co. and France's Sanofi SA. While it wasn't a completely smooth ride — 2016 was dire — Novo has never seen operational and strategic challenges on the scale it's now facing. In developing Ozempic for diabetes and its sibling Wegovy for weight loss, the company suddenly found itself riding a tiger.
Yahoo
20 minutes ago
- Yahoo
Gonorrhoea vaccination appointments open
A new vaccine against gonorrhoea will be rolled out in August following a rise in cases. The illness is the most common sexually transmitted infection in Northern Ireland It will not be available for everyone initially, the focus will be on gay and bisexual men who have a recent history of multiple sexual partners or have recently had a sexually transmitted infection (STI). England will also begin its vaccination roll out in August this year. The Joint Committee on Vaccination and Immunisation (JCVI) recommended roll out of the vaccine in November 2023 following an upsurge in gonorrhoea cases. Rachel Spiers, Immunisation and Vaccination Programme Manager at the PHA, said around eight out of 10 gonorrhoea infections occur in men. "Gay and bisexual men are most commonly affected, so by offering the vaccine to those most at risk it will not only help to protect them against the disease but will also help to reduce the spread," she added. The vaccine is an existing one for meningococcal B disease, called 4CMenB. The UK Health Security Agency (UKHSA) research shows that those who receive the jab could be protected from the STI by up to 40% and it could help tackle levels of antibiotic-resistant strains of the disease. The vaccine will be available through GUM clinics within regional Health and Social Care Trusts. Gonorrhoea diagnoses in NI have risen sharply since 2022. There were 1606 gonorrhoea diagnoses in 2022, which was two and a half times higher than the previous year, and this high level of gonorrhoea diagnosis was sustained in 2023. There was a small decline in 2024 to 1,208 cases, according to PHA data. What is gonorrhoea? Gonorrhoea does not always have symptoms, but they can include pain, unusual discharge, inflammation of the genitals and infertility. It is easily passed from person to person through unprotected sex. The infection can be passed from a pregnant woman to her baby, and without treatment, can cause permanent blindness for a newborn baby. It is not spread by non-sexual contact like hugging. It is not transmitted through surfaces and materials like toilet seats, towels, cups or plates. If you have had successful treatment for gonorrhoea before, you can still catch it again. Source: NHS.
Yahoo
3 hours ago
- Yahoo
'I'm in control of my sexual health' - UK gonorrhoea vaccine rollout begins
Gonorrhoea vaccines will be widely available from today in sexual health clinics across the UK, in a bid to tackle record-breaking levels of infections. The jabs will first be offered to those at highest risk - mostly gay and bisexual men who have a history of multiple sexual partners or sexually transmitted infections. NHS England say the roll out is a world-first, and predict it could prevent as many as 100,000 cases, potentially saving the NHS almost £8m over the next decade. The Terrence Higgins Trust, who campaigned for the vaccine to be introduced in the UK, told the BBC it was "a huge win" for sexual health. Gonorrhoea is a bacterial infection that is transmitted through unprotected sex. Symptoms can include pain, unusual discharge, inflammation of the genitals and infertility, but in some cases it can have no symptoms at all. The NHS says it can be avoided by the proper use of condoms and by accepting the vaccine if offered. Doctors are becoming increasingly worried about the number of infections, and hope the vaccine, which is 30-40% effective, will also help slow the growing number of antibiotic-resistant cases. The vaccine, known as the 4CMenB vaccine, was designed for preventing meningitis B in babies, but the bacteria that causes the two diseases are so closely related that the jab is also effective against gonorrhoea. There were more than 85,000 cases of gonorrhoea in 2023 - the highest since records began almost 100 years ago. One of those diagnosed was Joey Knock, who says the infection gave him diarrhoea, made him feel "wiped out" and led to him taking time off work to recover. He told BBC News: "I discussed it with my friends and I definitely had worse symptoms [than them] with it. "I felt really bad, I couldn't keep food down and I just felt totally run down." Because he has many sexual partners, the 35-year-old decided to pay a private pharmacy for a course of gonorrhoea vaccinations in February 2024 before travelling abroad to a festival. He paid £220 and says he's glad he did it. "It helps knowing that I'm taking control of my sexual health and doing what I can to stay safe and practise safer sex and be much less worried about the severity of the symptoms," he says. Joey says he uses the protection the vaccine offers him alongside other methods of safer sex, including taking PrEP, a drug which helps prevent HIV, and DoxyPep - antibiotics taken after sex to prevent bacterial STIs, a treatment not widely available on the NHS. He says he also occasionally uses condoms - but sees the vaccine as an extra tool to keep him safe in situations where he or his partner doesn't want to use them. Since being vaccinated, Joey has been re-infected with gonorrhoea but says the symptoms were much less severe. He told the BBC: "I've been able to get on with my day and it has just become something much more manageable, and getting tested regularly and knowing my body really helps too." Matthew, a 63-year-old from East Scotland, was diagnosed with gonorrhoea 10 years ago and had a reaction known as reactive arthritis - extreme pain in your joints caused by your body's reaction to an infection. He told the BBC that the experience, which has caused lasting damage to some of his fingers and toes, was so painful it's left him fearful of becoming re-infected and has impacted his mental health. He says: "I'm constantly looking for symptoms and I'm constantly aware of it, and I feel a bit like I used to do in the 1980s when I was constantly fretting about HIV. "I'd get some sort of cough and think 'oh my god, what's happening?'" He is hoping to be one of the first people to get a vaccine in order to give himself and his sexual partners more protection. "You're not just protecting yourself, you're protecting your partners. "I think it will also relieve some of the burden on sexual health services, it's getting difficult to get appointments so if it can work to reduce the incidence of STIs I think it's really worth it." Richard Angell, chief executive of the Terrence Higgins Trust, a leading sexual health charity, told the BBC the vaccine was a "remarkable addition to our toolkit on sexual health". Dr Amanda Doyle, NHS national director for primary care and community services, said it was important "everyone eligible takes up the offer through sexual health services" in order to "keep each other safe". "It's a real step forward for sexual health," she added. People who may be eligible for the vaccine are being asked to contact their local sexual health clinic for more information. Pride in London returns as events struggle with falling funds 'I had a criminal record for 56 years for being a lesbian - nobody told me' 'Our love is frowned upon, but we push through': Navigating religion and relationships
